A2M is naturally contained in blood plasma and acts as an important carrier for numerous proteins and growth factors. It is part of a family of protease inhibitors, meaning that it can deactivate a variety of proteinases that typically degrade cartilage by reducing inflammation in arthritic joints.
Research suggests that A2M may potentially halt the degenerative process in arthritis. Studies have suggested that A2M can protect cartilage cells (chondrocytes) in post-traumatic osteoarthritis.
At Orthohealing, we implement A2M when patients have an excess amount of inflammation or bursitis.